IPO - NLS Pharmaceutics Ltd.

Form Type: CORRESP

Filing Date: 2024-11-25

Corporate Action: Ipo

Type: New

Accession Number: 000121390024102320

Filing Summary: NLS Pharmaceutics Ltd. has requested the acceleration of the effective date of its Registration Statement on Form F-3, specifically to have it declared effective on November 26, 2024, at 4:30 p.m. Eastern Time. This request follows Rule 461 under the Securities Act of 1933, indicating the company's intent to proceed with a proposed public offering of securities as detailed in the Registration Statement. The company acknowledges its responsibilities regarding this offering and has asked for notification of the effectiveness both by telephone and in writing.

Document Link: View Document